POSSIBLE ANALYSES with V-Veil UP2TM
- HPV genotyping
- Vaginal Microbiome
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Ureaplasma parvum/
- Ureaplasma urealyticum
- Mycoplasma Genitalium
- Mycoplasma hominis
- Trichomonas vaginalis
- Gardnerella vaginalis
- Herpes Simplex virus 1
- Herpes Simplex virus 2
- Syphilis (Treponema pallidum)
V-Veil UP2TM KITs are
- Self-Sampling Medical Devices CLASS I according to Regulation (EU) 2017/745 (CE mark under the responsibility of the manufacturer).
- Produced in EN ISO 13485:2016 certified facility, in ISO 8 clean rooms.
- V-Veil UP2TM is listed as medical device for self-sampling into technology landscape report of Unitaid: Screening precancerous lesions for secondary prevention of cervical cancer.
- The Patented Veil Technology is engineered for higher yield: 0.7% DNA and 81.3% protein release
- The stability of the V-Veil UP2TM collected sample in dry media without any kind of liquid) at temperatures between 4 to 40°C is 30 days and at 50°C is 7 days.
- V-Veil UP2TM is simple, safe, and respects the privacy of all women.
- For women as final user, the KIT 4.1 and KIT 4.3 are available for on-line buying, in EU, at test-hpv.shop